Bank of Montreal’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,227
Closed -$37.6K 3711
2025
Q1
$37.6K Buy
15,227
+695
+5% +$1.65K ﹤0.01% 3116
2024
Q4
$45.6K Sell
14,532
-134,103
-90% -$649K ﹤0.01% 3126
2024
Q3
$733K Buy
+148,635
New +$767K ﹤0.01% 2193
2023
Q3
Sell
-93,315
Closed -$1.85M 4191
2023
Q2
$1.85M Buy
+93,315
New +$1.91M ﹤0.01% 1856

Other funds holding SLRN

Bank of Montreal's SLRN Position: Q2 2025 in Review

Bank of Montreal sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 15,227 shares — an estimated $37.6K sold.

Bank of Montreal first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $1.85M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Bank of Montreal reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Bank of Montreal sold 15,227 ACELYRIN shares in Q2 2025, an estimated $37.6K.
  • Bank of Montreal first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
  • Bank of Montreal's ACELYRIN position peaked at $1.85M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.